Sökning: onr:"swepub:oai:gup.ub.gu.se/331172" >
Phase II study of e...
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.
-
- Morken, Siren (författare)
- Haukeland University Hospital
-
- Langer, Seppo W (författare)
- Copenhagen University Hospital,University of Copenhagen
-
- Sundlöv, Anna (författare)
- Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine
-
visa fler...
-
- Vestermark, Lene Weber (författare)
- Odense University Hospital
-
- Ladekarl, Morten (författare)
- Aarhus University Hospital,Aalborg University
-
- Hjortland, Geir Olav (författare)
- Oslo university hospital
-
- Svensson, Johanna (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology,Sahlgrenska University Hospital
-
- Tabaksblat, Elizaveta Mitkina (författare)
- Aarhus University Hospital
-
- Haslerud, Torjan Magne (författare)
- Haukeland University Hospital
-
- Assmus, Jörg (författare)
- Haukeland University Hospital
-
- Detlefsen, Sönke (författare)
- Odense University Hospital,University of Southern Denmark
-
- Couvelard, Anne (författare)
- Hopital Bichat-Claude-Bernard AP-HP
-
- Perren, Aurel (författare)
- University of Bern
-
- Sorbye, Halfdan (författare)
- Haukeland University Hospital,University of Bergen
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska.
-
Ingår i: British journal of cancer. - 0007-0920 .- 1532-1827. ; 129:12, s. 1930-1939
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
https://lup.lub.lu.s...
-
visa färre...
Abstract
Ämnesord
Stäng
- The optimal treatment for metastatic high-grade gastroenteropancreatic (GEP) neuroendocrine neoplasms when Ki-67 ≤55% is unknown. A prospective multi-centre phase 2 study was performed to evaluate the efficacy andsafety of everolimus and temozolomide as first-line treatment for these patients.Patients received everolimus 10mg daily continuously and temozolomide 150mg/m2 for 7 days every 2 weeks. Endpoints included response, survival, safety and quality of life (QoL). Histopathological re-evaluation according to the 2019 WHO classification was performed.For 37 eligible patients, the primary endpoint with 65% disease control rate (DCR) at 6 months (m) was reached. The response rate was 30%, the median progression-free survival (PFS) 10.2months and the median overall survival (OS) 26.4months. Considering 26 NET G3 patients, 6months DCR was 77% vs. 22% among nine NEC patients (p=0.006). PFS was superior for NET G3 vs. NEC (12.6months vs. 3.4months, Log-rank-test: p=0.133, Breslow-test: p<0.001). OS was significantly better for NET G3 (31.4months vs. 7.8months, p=0.003). Grade 3 and 4 toxicities were reported in 43% and 38%. QoL remained stable during treatment.Everolimus and temozolomide may be a treatment option for selected GEP-NET G3 patients including careful monitoring. Toxicity did not compromise QoL.ClinicalTrials.gov (NTC02248012).
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Morken, Siren
-
Langer, Seppo W
-
Sundlöv, Anna
-
Vestermark, Lene ...
-
Ladekarl, Morten
-
Hjortland, Geir ...
-
visa fler...
-
Svensson, Johann ...
-
Tabaksblat, Eliz ...
-
Haslerud, Torjan ...
-
Assmus, Jörg
-
Detlefsen, Sönke
-
Couvelard, Anne
-
Perren, Aurel
-
Sorbye, Halfdan
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
British journal ...
- Av lärosätet
-
Göteborgs universitet
-
Lunds universitet